Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of pimodivir plus standard of care for outpatient influenza A at risk of complications
MOH_2018-04-29_002348Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Influenza A infection comparing Pimodivir + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Time to resolution of influenza-related symptoms. Started Feb 2018; status: completed.
02
Drugs
pimodivir
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on MOH_2018-04-29_002348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-04-29_002348.